HL
CME icon

Harding Loevner’s CME Group CME Stock Holding History

Harding Loevner’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.9M Sell
338,257
-255,021
-43% -$75.7M 1.03% 32
2025
Q4 		$162M Sell
593,278
-97,149
-14% -$26.4M 1.43% 26
2025
Q3 		$187M Sell
690,427
-256,381
-27% -$69.8M 1.37% 24
2025
Q2 		$261M Buy
946,808
+17,444
+2% +$4.74M 1.76% 18
2025
Q1 		$247M Sell
929,364
-170,511
-16% -$42.1M 1.89% 19
2024
Q4 		$255M Sell
1,099,875
-219,288
-17% -$50.4M 1.73% 20
2024
Q3 		$291M Buy
1,319,163
+197,050
+18% +$40.8M 1.68% 20
2024
Q2 		$221M Sell
1,122,113
-36,845
-3% -$7.61M 1.22% 31
2024
Q1 		$250M Sell
1,158,958
-95,781
-8% -$20.1M 1.54% 25
2023
Q4 		$264M Sell
1,254,739
-22,669
-2% -$4.84M 1.48% 24
2023
Q3 		$256M Sell
1,277,408
-177,538
-12% -$35.3M 1.69% 22
2023
Q2 		$270M Sell
1,454,946
-224,674
-13% -$41.5M 1.57% 22
2023
Q1 		$322M Buy
1,679,620
+625,583
+59% +$113M 1.83% 19
2022
Q4 		$177M Buy
1,054,037
+109,192
+12% +$19M 1.02% 38
2022
Q3 		$167M Sell
944,845
-54,634
-5% -$10.8M 1.1% 29
2022
Q2 		$205M Sell
999,479
-313,819
-24% -$66.5M 1.26% 24
2022
Q1 		$266M Sell
1,313,298
-111,506
-8% -$26.2M 1.47% 24
2021
Q4 		$326M Sell
1,424,804
-28,894
-2% -$6.36M 1.25% 32
2021
Q3 		$281M Sell
1,453,698
-82,725
-5% -$16.8M 1.12% 32
2021
Q2 		$327M Sell
1,536,423
-986,293
-39% -$208M 1.23% 30
2021
Q1 		$515M Buy
2,522,716
+759,390
+43% +$150M 2.02% 20
2020
Q4 		$321M Buy
1,763,326
+177,375
+11% +$30.2M 1.33% 26
2020
Q3 		$265M Buy
+1,585,951
New +$267M 0.96% 34

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harding Loevner's CME Position: Q1 2026 in Review

Harding Loevner reduced its CME Group (CME) stake by 43% in Q1 2026, selling an estimated $75.7M and leaving 338,257 shares worth $99.9M. The position accounts for 1.03% of the portfolio, ranked #32.

Harding Loevner first reported a position in CME in Q3 2020 and has held it in 23 quarters since. The position peaked at $515M in Q1 2021. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Harding Loevner held 338,257 shares of CME Group worth $99.9M as of Q1 2026.
  • Harding Loevner sold 255,021 CME Group shares in Q1 2026, an estimated $75.7M.
  • CME Group made up 1.03% of Harding Loevner's portfolio in Q1 2026, its #32 holding.
  • Harding Loevner first reported a position in CME Group in Q3 2020 and has held it in 23 quarters since.
  • Harding Loevner's CME Group position peaked at $515M in Q1 2021.
  • 1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Harding Loevner's 13F filing for Q1 2026, filed 15 May 2026.